{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/09/14/3361592/0/en/ascendis-to-regain-rights-to-transcon-technology-in-metabolic-and-cardiovascular-diseases.html", "message": "News view counter 933146 successfully enlarged"}